Overview

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

Status:
RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine whether administration of ketanserin (40 mg), olanzapine (10 mg), and lorazepam (2 mg) after administration of LSD (150 µg) attenuates and shortens the subjective LSD response (any drug effect) compared to administration of LSD (150 µg) alone
Phase:
PHASE1
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Ketanserin
Lorazepam
Lysergic Acid Diethylamide
Olanzapine